These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12096013)

  • 1. Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents.
    Ednie LM; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2002 Jul; 50(1):101-5. PubMed ID: 12096013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of linezolid against anaerobic bacteria.
    Behra-Miellet J; Calvet L; Dubreuil L
    Int J Antimicrob Agents; 2003 Jul; 22(1):28-34. PubMed ID: 12842325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents.
    Ednie LM; Rattan A; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1143-7. PubMed ID: 12604558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species.
    Credito KL; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4430-4. PubMed ID: 15504874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipneumococcal activity of AZD2563, a new oxazolidinone, compared with nine other agents.
    Peric M; Lin G; Clark CL; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2002 Jul; 50(1):95-100. PubMed ID: 12096012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
    Watt B; Naden M
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():119-24. PubMed ID: 2808203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual gram-positive species.
    Jones RN; Biedenbach DJ; Anderegg TR
    Diagn Microbiol Infect Dis; 2002 Feb; 42(2):119-22. PubMed ID: 11858907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary susceptibility testing guidelines for AZD2563, a long-acting oxazolidinone.
    Anderegg TR; Jones RN
    Int J Antimicrob Agents; 2004 Jan; 23(1):6-10. PubMed ID: 14732307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomycetes, and lactobacilli.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT; Bryskier A
    Antimicrob Agents Chemother; 2005 Jan; 49(1):408-13. PubMed ID: 15616322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.
    Smith PF; Booker BM; Ogundele AB; Kelchin P
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):255-9. PubMed ID: 15935606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 1-1. Anaerobic infections (General): epidemiology of anaerobic infections.
    ;
    J Infect Chemother; 2011 Jul; 17 Suppl 1():4-12. PubMed ID: 21728084
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of AZD2563, a novel oxazolidinone, against European Gram-positive cocci.
    Fluit AC; Schmitz FJ; Verhoef J; Milatovic D
    J Antimicrob Chemother; 2002 Aug; 50(2):271-6. PubMed ID: 12161411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of AZD2563, a new oxazolidinone, tested against beta-haemolytic and viridans group streptococci.
    Anderegg TR; Biedenbach DJ; Jones RN
    J Antimicrob Chemother; 2002 Jun; 49(6):1019-21. PubMed ID: 12039896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2003 Jan; 47(1):337-41. PubMed ID: 12499210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in-vitro activity of linezolid (U-100766) and tentative breakpoints.
    Wise R; Andrews JM; Boswell FJ; Ashby JP
    J Antimicrob Chemother; 1998 Dec; 42(6):721-8. PubMed ID: 10052894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
    Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
    Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections.
    Odou MF; Muller C; Calvet L; Dubreuil L
    J Antimicrob Chemother; 2007 Apr; 59(4):646-51. PubMed ID: 17350985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of PH-027 versus linezolid and other anti-anaerobic antimicrobials against clinical isolates of Clostridium difficile and other anaerobic bacteria.
    Phillips OA; Rotimi VO; Jamal WY; Shahin M; Verghese TL
    J Chemother; 2003 Apr; 15(2):113-7. PubMed ID: 12797385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2149-52. PubMed ID: 15155214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of LCB01-0062, a novel oxazolidinone.
    Jung SJ; Yun IN; Park HS; Lee HH; Jeong JW; Kim YZ; Cho YL; Kwak JH
    Int J Antimicrob Agents; 2012 Dec; 40(6):539-43. PubMed ID: 23058227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.